Ascending Triangle in Amgen?

Amgen has been stuck at its current price area for almost 3-1/2 years, but now some traders may expect its longer-term uptrend to resume.

The first pattern on today’s chart is the $255-260 price zone. It roughly matches peaks in the summer of 2020, the spring of 2021 and the spring of 2022. AMGN ripped through it late last year, pulled back and stalled at the same price area in April of this year.

Strong earnings drove the pharma stock above that level in August. It was subsequently tested in September and late October, with prices remaining above. Has old resistance become new support?

Second is the series of higher lows since the last dip. The resulting ascending triangle is a potentially bullish continuation pattern.

Third, the 50-day simple moving average (SMA) had a “golden cross” above the 200-day SMA in mid-September. That may suggest the longer-term trend is getting more positive.

Finally, the lower study features our 2 MA Ratio custom script with the default settings of the 8-day and 21-day exponential moving averages (EMAs). It just turned positive, meaning the faster EMA has risen above slower EMA. That may suggest the shorter-term trend is getting more positive.

TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more.

Important Information

Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures or cryptocurrencies); therefore, you should not invest or risk money that you cannot afford to lose. Online trading is not suitable for all investors. View the document titled Characteristics and Risks of Standardized Options at https://www.TradeStation.com/DisclosureOptions. Before trading any asset class, customers must read the relevant risk disclosure statements on https://www.TradeStation.com/Important-Information/. System access and trade placement and execution may be delayed or fail due to market volatility and volume, quote delays, system and software errors, Internet traffic, outages and other factors.

Securities and futures trading is offered to self-directed customers by TradeStation Securities, Inc., a broker-dealer registered with the Securities and Exchange Commission (“SEC”) and a futures commission merchant licensed with the Commodity Futures Trading Commission (“CFTC”). TradeStation Securities is a member of the Financial Industry Regulatory Authority, the National Futures Association (“NFA”), and a number of exchanges. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services under federal and state money services business/money-transmitter and similar registrations and licenses.

TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a member of NFA. When applying for, or purchasing, accounts, subscriptions, products and services, it is important that you know which company you will be dealing with. Visit https://www.TradeStation.com/DisclosureTSCompanies for further important information explaining what this means.
Moving AveragesSupport and ResistanceTriangle

Aviso legal